Demonstrating Analytical Similarity of Trastuzumab Biosimilar HLX02 to Herceptin® With a Panel of Sensitive and Orthogonal Methods Including a Novel FcγRIIIa Affinity Chromatography Technology
BioDrugs - United Kingdom
doi 10.1007/s40259-020-00407-0
Full Text
Open PDFAbstract
Available in full text
Date
February 18, 2020
Authors
Publisher
Springer Science and Business Media LLC